SwePub
Sök i LIBRIS databas

  Utökad sökning

WFRF:(Heymann D)
 

Sökning: WFRF:(Heymann D) > International conse...

LIBRIS Formathandbok  (Information om MARC21)
FältnamnIndikatorerMetadata
00005789naa a2201153 4500
001oai:gup.ub.gu.se/160546
003SwePub
008240528s2012 | |||||||||||000 ||eng|
009oai:prod.swepub.kib.ki.se:124954831
024a https://gup.ub.gu.se/publication/1605462 URI
024a https://doi.org/10.1111/j.1398-9995.2012.02865.x2 DOI
024a http://kipublications.ki.se/Default.aspx?queryparsed=id:1249548312 URI
040 a (SwePub)gud (SwePub)ki
041 a eng
042 9 SwePub
072 7a ref2 swepub-contenttype
072 7a art2 swepub-publicationtype
100a Papadopoulos, N G4 aut
2451 0a International consensus on (ICON) pediatric asthma.
264 c 2012-06-15
264 1b Wiley,c 2012
520 a Asthma is the most common chronic lower respiratory disease in childhood throughout the world. Several guidelines and/or consensus documents are available to support medical decisions on pediatric asthma. Although there is no doubt that the use of common systematic approaches for management can considerably improve outcomes, dissemination and implementation of these are still major challenges. Consequently, the International Collaboration in Asthma, Allergy and Immunology (iCAALL), recently formed by the EAACI, AAAAI, ACAAI, and WAO, has decided to propose an International Consensus on (ICON) Pediatric Asthma. The purpose of this document is to highlight the key messages that are common to many of the existing guidelines, while critically reviewing and commenting on any differences, thus providing a concise reference. The principles of pediatric asthma management are generally accepted. Overall, the treatment goal is disease control. To achieve this, patients and their parents should be educated to optimally manage the disease, in collaboration with healthcare professionals. Identification and avoidance of triggers is also of significant importance. Assessment and monitoring should be performed regularly to re-evaluate and fine-tune treatment. Pharmacotherapy is the cornerstone of treatment. The optimal use of medication can, in most cases, help patients control symptoms and reduce the risk for future morbidity. The management of exacerbations is a major consideration, independent of chronic treatment. There is a trend toward considering phenotype-specific treatment choices; however, this goal has not yet been achieved.
650 7a MEDICIN OCH HÄLSOVETENSKAPx Klinisk medicinx Pediatrik0 (SwePub)302212 hsv//swe
650 7a MEDICAL AND HEALTH SCIENCESx Clinical Medicinex Pediatrics0 (SwePub)302212 hsv//eng
650 7a MEDICIN OCH HÄLSOVETENSKAPx Klinisk medicinx Lungmedicin och allergi0 (SwePub)302192 hsv//swe
650 7a MEDICAL AND HEALTH SCIENCESx Clinical Medicinex Respiratory Medicine and Allergy0 (SwePub)302192 hsv//eng
700a Arakawa, H4 aut
700a Carlsen, K-H4 aut
700a Custovic, A4 aut
700a Gern, J4 aut
700a Lemanske, R4 aut
700a Le Souef, P4 aut
700a Mäkelä, M4 aut
700a Roberts, G4 aut
700a Wong, G4 aut
700a Zar, H4 aut
700a Akdis, C A4 aut
700a Bacharier, L B4 aut
700a Baraldi, E4 aut
700a van Bever, H P4 aut
700a de Blic, J4 aut
700a Boner, A4 aut
700a Burks, W4 aut
700a Casale, T B4 aut
700a Castro-Rodriguez, J A4 aut
700a Chen, Y Z4 aut
700a El-Gamal, Y M4 aut
700a Everard, M L4 aut
700a Frischer, T4 aut
700a Geller, M4 aut
700a Gereda, J4 aut
700a Goh, D Y4 aut
700a Guilbert, T W4 aut
700a Hedlin, Gu Karolinska Institutet4 aut
700a Heymann, P W4 aut
700a Hong, S J4 aut
700a Hossny, E M4 aut
700a Huang, J L4 aut
700a Jackson, D J4 aut
700a de Jongste, J C4 aut
700a Kalayci, O4 aut
700a Aït-Khaled, N4 aut
700a Kling, S4 aut
700a Kuna, P4 aut
700a Lau, S4 aut
700a Ledford, D K4 aut
700a Lee, S I4 aut
700a Liu, A H4 aut
700a Lockey, R F4 aut
700a Lødrup-Carlsen, K4 aut
700a Lötvall, Jan,d 1956u Gothenburg University,Göteborgs universitet,Krefting Research Centre4 aut0 (Swepub:gu)xlotja
700a Morikawa, A4 aut
700a Nieto, A4 aut
700a Paramesh, H4 aut
700a Pawankar, R4 aut
700a Pohunek, P4 aut
700a Pongracic, J4 aut
700a Price, D4 aut
700a Robertson, C4 aut
700a Rosario, N4 aut
700a Rossenwasser, L J4 aut
700a Sly, P D4 aut
700a Stein, R4 aut
700a Stick, S4 aut
700a Szefler, S4 aut
700a Taussig, L M4 aut
700a Valovirta, E4 aut
700a Vichyanond, P4 aut
700a Wallace, D4 aut
700a Weinberg, E4 aut
700a Wennergren, Göran,d 1947u Gothenburg University,Göteborgs universitet,Institutionen för kliniska vetenskaper, Avdelningen för pediatrik,Institute of Clinical Sciences, Department of Pediatrics4 aut0 (Swepub:gu)xwengo
700a Wildhaber, J4 aut
700a Zeiger, R S4 aut
710a Karolinska Institutetb Krefting Research Centre4 org
773t Allergyd : Wileyg 67:8, s. 976-97q 67:8<976-97x 1398-9995x 0105-4538
856u https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/j.1398-9995.2012.02865.x
8564 8u https://gup.ub.gu.se/publication/160546
8564 8u https://doi.org/10.1111/j.1398-9995.2012.02865.x
8564 8u http://kipublications.ki.se/Default.aspx?queryparsed=id:124954831

Hitta via bibliotek

  • Allergy (Sök värdpublikationen i LIBRIS)

Till lärosätets databas

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy